134 related articles for article (PubMed ID: 23111976)
1. The immunohistochemical detection of P16 and HPV L1 capsid protein on cell block sections from residual PapSpin liquid-based gynecology cytology specimens as a diagnostic and prognostic tool.
Haltas H; Bayrak R; Yenidunya S; Yildirim U
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1588-95. PubMed ID: 23111976
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
Yu L; Wang L; Zhong J; Chen S
Cancer Cytopathol; 2010 Feb; 118(1):47-55. PubMed ID: 20069634
[TBL] [Abstract][Full Text] [Related]
3. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
5. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Cancer; 2008 Apr; 114(2):83-8. PubMed ID: 18300235
[TBL] [Abstract][Full Text] [Related]
7. Estimating clinical outcome of HPV induced cervical lesions by combination of capsid protein L1 and p16INK4a protein detection.
Bolanca IK; Sentija K; Simon SK; Kukura V; Vranes J
Coll Antropol; 2010 Mar; 34(1):31-6. PubMed ID: 20432730
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
Alshenawy HA
Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions.
Izadi-Mood N; Sarmadi S; Eftekhar Z; Jahanteegh HA; Sanii S
Arch Gynecol Obstet; 2014 Jun; 289(6):1287-92. PubMed ID: 24346122
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions.
Xiao W; Bian M; Ma L; Liu J; Chen Y; Yang B; Wu Q
Acta Cytol; 2010; 54(5):661-7. PubMed ID: 20968152
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
Yemelyanova A; Gravitt PE; Ronnett BM; Rositch AF; Ogurtsova A; Seidman J; Roden RB
Mod Pathol; 2013 Feb; 26(2):268-74. PubMed ID: 22996373
[TBL] [Abstract][Full Text] [Related]
16. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material.
Akpolat I; Smith DA; Ramzy I; Chirala M; Mody DR
Cancer; 2004 Jun; 102(3):142-9. PubMed ID: 15211472
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical values of HPV L1 and p16INK4a protein in uterine cervical lesions].
Song Y; Li Q; Li L; Chen W; Shen GH; Qiao YL; Zhang X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):352-5. PubMed ID: 22883455
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
19. Utility of Human Papillomavirus Capsid Protein L1 and p16 in the Assessment and Accurate Classification of Anal Squamous Intraepithelial Lesions.
Patil DT; Yang B
Am J Clin Pathol; 2015 Jul; 144(1):113-21. PubMed ID: 26071469
[TBL] [Abstract][Full Text] [Related]
20. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]